NCT06935786 SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease
| NCT ID | NCT06935786 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Turku University Hospital |
| Condition | Chronic Kidney Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-02-21 |
| Primary Completion | 2031-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-02-21 with a primary completion date of 2031-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn if a simple home exercise program can benefit patients with advanced chronic kidney disease. There is also an observational part of the study without an exercise program. The study will record patients' mortality, cardiovascular events, emergency department visits, hospital stays, need for dialysis and 6 minutes walking distance. Also maximal oxygen uptake, quality of life and bone fractures are recorded and blood tests and X-rays analyzed. The prospective observational part of the study will investigate the link between cardiovascular and kidney health as well as exercise capacity and adverse outcomes.
Eligibility Criteria
Inclusion Criteria: * Age \>40 years * Estimated glomerular filtration rate \< 20ml/min/1.73m2 (CKD stage 4-5) * Informed consent from the patient is received Exclusion Criteria: * Maintenance dialysis dependency before inclusion * Pregnant women * Patient's lack of commitment to follow-up * Chronic or acute clinical condition with a prognosis less than 6 months * Amputated lower limbs
Contact & Investigator
Tapio Hellman, MD, PhD
PRINCIPAL INVESTIGATOR
Turku University Hospital and University of Turku
Frequently Asked Questions
Who can join the NCT06935786 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06935786 currently recruiting?
Yes, NCT06935786 is actively recruiting participants. Contact the research team at markus.hakamaki@tyks.fi for enrollment information.
Where is the NCT06935786 trial being conducted?
This trial is being conducted at Pori, Finland, Turku, Finland, Vaasa, Finland.
Who is sponsoring the NCT06935786 clinical trial?
NCT06935786 is sponsored by Turku University Hospital. The principal investigator is Tapio Hellman, MD, PhD at Turku University Hospital and University of Turku. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.